This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Context. ACT-660602 (Idorsia Pharmaceuticals) is an oral chemokine receptor CXCR3 antagonist being developed for autoimmune diseases. Chemokines and their receptors…
molecule
1 year ago ●
3 mins read
Assume a cow is an evenly distributed sphere... sometimes. I happened to take an animal physiology course in college because…
Article
3 years ago ●
5 mins read
Context. “Compound 7” (NIBR) is an oral Trypanosoma brucei 20S proteasome inhibitor being developed for Human African Trypanosomiasis (HAT). African…
molecule
1 year ago ●
5 mins read
At the time of this writing Kim Huard was one of Genentech’s Senior Scientists, and has spent a decade looking…
Article
4 years ago ●
8 mins read
Context. SPH3127 (Mitsubishi Tanabe and Shanghai Pharmaceuticals) is an oral direct renin inhibitor (DRI) being developed for hypertension. The renin-angiotensin-aldosterone…
molecule
1 year ago ●
5 mins read
This post briefly introduces chimeric molecules and companies working on them, contains a list of 10 recent “hot” papers in…
Article
4 years ago ●
8 mins read
Load More
